Gyre Therapeutics (GYRE) Operating Margin Growth (3y) (2013 - 2026)
Gyre Therapeutics (GYRE) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
-6,827.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-6,827.00 |
| Dec 31, 2025 |
-29.00 |
| Mar 31, 2025 |
186,182.00 |
| Dec 31, 2024 |
83,489.00 |
| Sep 30, 2024 |
111,400.00 |
| Jun 30, 2024 |
177,185.00 |
| Mar 31, 2024 |
155,922.00 |
| Dec 31, 2023 |
59,014.00 |
| Sep 30, 2023 |
184,275.00 |
| Jun 30, 2023 |
106,406.00 |
| Mar 31, 2023 |
5,770.00 |
| Mar 31, 2021 |
10.98 Mn |
| Dec 31, 2020 |
90,535.00 |
| Sep 30, 2020 |
4,552.00 |
| Jun 30, 2020 |
430,785.00 |
| Mar 31, 2020 |
150,815.00 |
| Mar 31, 2018 |
-11.09 Mn |
| Dec 31, 2017 |
-156,546.00 |
| Sep 30, 2017 |
-154,898.00 |
| Jun 30, 2017 |
-461,085.00 |
